NRIX Sale Disclosure
Ring Christine · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$157.92K
Ring Christine Chief Legal Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Nov 3, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 1 day later
NRIX daily price context
Close on/before transaction
$25.82
Nov 3, 2026
First close after public filing
$14.84
Nov 5, 2026
Return after filing · so far
+3.1%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,113 shares @ $25.83
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817199-26-000036
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$482.36K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX Current | Sale | Nov 3, 2026 | $157.92K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Nov 2, 2026 | $50.45K |
| Nurix Therapeutics, Inc. NRIX | Sale | Nov 2, 2026 | $245.22K |
| Nurix Therapeutics, Inc. NRIX | Sale | Nov 2, 2026 | $28.77K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Nov 2, 2026 | $0 |